Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity
Voriconazole (VCZ), a triazole with a large spectrum of action is one of the most recommended antifungal agents as the first line therapy against several clinically important systemic fungal infections, including those by Candida albicans. This antifungal has moderate water solubility and exhibits a...
Saved in:
Main Authors: | Danillo F. M. C. Veloso (Author), Naiara I. G. M. Benedetti (Author), Renato I. Ávila (Author), Thiago S. A. Bastos (Author), Thaísa C. Silva (Author), Maria R. R. Silva (Author), Aline C. Batista (Author), Marize C. Valadares (Author), Eliana M. Lima (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016) -
Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021) -
The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients
by: Cheng L, et al.
Published: (2024) -
Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
by: Zahra Golestannejad, et al.
Published: (2022) -
Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients
by: Hamidreza Taghvaye Masoumi, et al.
Published: (2017)